Department of Orthopaedics and Traumatology, Develi Hatice-Muammer Kocaturk State Hospital, Kayseri, Turkey.
Department of Orthopaedics and Traumatology, Ataturk Training and Research Hospital, Ankara, Turkey.
J Arthroplasty. 2019 Nov;34(11):2614-2619. doi: 10.1016/j.arth.2019.06.043. Epub 2019 Jun 26.
To the best of our knowledge, there have been no studies in the literature related to the use of second-generation inlay patellofemoral arthroplasty and unicompartmental knee arthroplasty combination (inlay PFA/UKA) in the treatment of mediopatellofemoral osteoarthritis (MPFOA). The aim of this study is to evaluate the efficacy of inlay PFA/UKA in MPFOA.
The study included 49 patients applied with inlay PFA/UKA because of MPFOA and 49 patients applied with TKA, matched one-to-one according to age, gender, body mass index, follow-up period, preoperative Knee Society Score, and range of motion. All the patients were evaluated clinically using the Knee Society Score, Knee Injury Osteoarthritis Outcome Score, and range of motion, and were also evaluated radiologically. Complication rates and length of hospital stay were compared.
The mean follow-up period was 54 ± 4 and 54.4 ± 3.9 months in inlay PFA/UKA and TKA groups, respectively. (P = .841). No statistically significant difference was determined between the 2 groups in respect of the mean clinical scores at the final follow-up examination (P ≥ .129). Total complications were fewer and length of hospital stay was shorter in the inlay PFA/UKA group than in the TKA group (P = .037 and P = .002). There was no radiographic evidence of progression of lateral compartment osteoarthritis according to Kellgren-Lawrence in any patient in the inlay PFA/UKA group.
In selected patient groups, inlay PFA/UKA is an alternative to TKA, with lower complication rates, shorter length of hospital stay, and clinical and functional results similar to those of TKA without osteoarthritis progression in the unresurfaced lateral compartment in the mid-term.
III.
据我们所知,目前文献中尚无关于第二代镶嵌式髌股关节成形术和单髁膝关节置换术联合应用(镶嵌 PFA/UKA)治疗内侧髌股关节骨关节炎(MPFOA)的研究。本研究旨在评估镶嵌 PFA/UKA 在 MPFOA 中的疗效。
该研究纳入了 49 例因 MPFOA 接受镶嵌 PFA/UKA 治疗的患者和 49 例接受 TKA 治疗的患者,按照年龄、性别、体重指数、随访时间、术前膝关节协会评分和关节活动度进行一对一匹配。所有患者均采用膝关节协会评分、膝关节损伤骨关节炎结果评分和关节活动度进行临床评估,并进行影像学评估。比较并发症发生率和住院时间。
镶嵌 PFA/UKA 和 TKA 组的平均随访时间分别为 54 ± 4 和 54.4 ± 3.9 个月(P =.841)。两组最终随访检查的平均临床评分无统计学差异(P ≥.129)。镶嵌 PFA/UKA 组的总并发症较少,住院时间较短(P =.037 和 P =.002)。在镶嵌 PFA/UKA 组中,根据 Kellgren-Lawrence 标准,没有患者出现外侧间室骨关节炎进展的影像学证据。
在选择的患者群体中,镶嵌 PFA/UKA 是 TKA 的一种替代方案,具有较低的并发症发生率、较短的住院时间以及与 TKA 相似的临床和功能结果,且未出现非表面化外侧间室的骨关节炎进展。
III 级。